Antiandrogenic effect of 16-substituted, non-substituted and D-homopregnane derivatives.
The pharmacological activities of 12 pregnane derivatives (4-15) were determined on gonadectomized male hamster flank organs and seminal vesicles as antiandrogens and as 5alpha-reductase inhibitors. The results from this study indicate that subcutaneous injection of testosterone for 3 d increased the diameter of the pigmented spot in the flank organs, whereas finasteride when injected with testosterone decreased the size of the spot significantly when steroids 4-15 were injected together with testosterone, the diameter of the flank organs of gonadectomized male hamsters, decreased significantly (p<0.005) compared to testosterone. Compound 11 was the most active steroid and reduced the diameter of the pigmented spot more than the other synthesized steroids or finasteride. Subcutaneous injections of testosterone to gonadectomized animals restore the seminal vesicle size lost upon castration. Injection of testosterone plus finasteride decreased significantly the weight of these glands (p<0.005). Steroids 5-15 when injected with testosterone decreased the weight of the seminal vesicles compared to testosterone. Finasteride is a good inhibitor of the conversion of testosterone to dihydrotestosterone (DHT) (low formation of DHT) measured as pmole of DHT/g of protein/h. Steroids 6-15 inhibited the conversion of testosterone to DHT as compared to testosterone however finasteride and 10 appeared to be the most effective compounds. Castration increases the protein content of the seminal vesicles (control) expressed as microg/mg of tissues. Testosterone tends to decrease it significantly, as did compounds 4, 5, 7, 9, and 15. We demonstrated that DHT as well as cyproterone acetate and steroids 5, 6, 8, 9, 11, and 14 at increasing non radioactive steroid concentration, inhibited the binding of [3H]DHT to cytosolic androgen receptor (AR), as indicated by its Ki values. However, 4, 7, 10, 12, and 13 did not have any inhibitory effect.
Bratoeff
E A
EA
Department of Pharmacy, Faculty of Chemistry, Ciudad Universitaria, Mexico D.F. Mexico. eugene@servidor.unam.mx
Herrera
H
H
Ramírez
E
E
Solorzano
K
K
Murillo
E
E
Quiróz
A
A
Cabeza
M
M
D000726:Androgen Antagonists / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D001667:Binding, Competitive / Q000187:drug effects; D006224:Cricetinae; D003600:Cytosol / Q000187:drug effects / Q000378:metabolism; D013196:Dihydrotestosterone / Q000378:metabolism; D005837:Genitalia, Male / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D008647:Mesocricetus; D009919:Orchiectomy; D009929:Organ Size; D011278:Pregnanes / Q000138:chemical synthesis* / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism; D012669:Seminal Vesicles / Q000187:drug effects; D013739:Testosterone / Q000378:metabolism
D000726:Androgen Antagonists; D011278:Pregnanes; D011506:Proteins; D013196:Dihydrotestosterone; D013739:Testosterone